Paris - Delayed Quote EUR

Median Technologies SA (ALMDT.PA)

4.8000

-0.3200

(-6.25%)

At close: January 17 at 5:35:02 PM GMT+1

Median Technologies: Financial Communications Schedule for the First Half of 2025

SOPHIA ANTIPOLIS, France, January 14, 2025--Median Technologies Financial Communications Schedule for the First Half of 2025.

Business Wire 4 days ago

ALMDT.PA
-6.25%
Half Year Median Technologies Liquidity Contract Statement

SOPHIA ANTIPOLIS, France, January 09, 2025--Half year Median Technologies liquidity contract statement

Business Wire 9 days ago

ALMDT.PA
-6.25%
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31st, 2024

SOPHIA ANTIPOLIS, France, January 08, 2025--Disclosure of total number of voting rights and number of shares in the capital as of December 31st, 2024.

Business Wire 10 days ago

ALMDT.PA
-6.25%
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2024

SOPHIA ANTIPOLIS, France, December 11, 2024--Regulatory News: Median Technologies (Paris:ALMDT):

Business Wire last month

ALMDT.PA
-6.25%
Median Technologies to Showcase AI-Powered Lung Cancer Diagnostic eyonis™ LCS at the Radiological Society of North America (RSNA) 2024

SOPHIA ANTIPOLIS, France, November 26, 2024--Median Technologies to showcase AI-powered lung cancer diagnostic eyonis™ LCS at the Radiological Society of North America (RSNA) 2024

Business Wire last month

ALMDT.PA
-6.25%
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2024

SOPHIA ANTIPOLIS, France, November 12, 2024--Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of October 31st, 2024.

Business Wire 2 months ago

ALMDT.PA
-6.25%
Median Technologies Hosted Insightful Key Opinion Leader (KOL) Webinar on eyonis™ Lung Cancer Screening (LCS) REALITY Data

SOPHIA-ANTIPOLIS, France, November 07, 2024--Median Technologies hosted insightful Key Opinion Leader (KOL) webinar on eyonis™ Lung Cancer Screening (LCS) REALITY data.

Business Wire 2 months ago

ALMDT.PA
-6.25%
Median Technologies to Host Key Opinion Leader (KOL) Webinar on AI and Lung Cancer Screening

SOPHIA-ANTIPOLIS, France, October 30, 2024--Median Technologies to host Key Opinion Leader (KOL) webinar on AI and lung cancer screening

Business Wire 2 months ago

ALMDT.PA
-6.25%
Median Technologies Reports 2024 Q3 Operational and Financial Update and 2024 Half-Year Results

SOPHIA ANTIPOLIS, France, October 24, 2024--Median Technologies Reports 2024 Q3 Operational and Financial Update and 2024 Half-Year Results

Business Wire 2 months ago

ALMDT.PA
-6.25%
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30th, 2024

SOPHIA ANTIPOLIS, France, October 07, 2024--Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of September 30th, 2024

Business Wire 3 months ago

ALMDT.PA
-6.25%
Median Technologies to Attend and Present at the ESMO Congress 2024, Being Held in Barcelona, Spain, from Sept 13-17, 2024

SOPHIA ANTIPOLIS, France, September 11, 2024--Median Technologies to attend and present at the ESMO Congress 2024, being held in Barcelona, Spain, from Sept 13-17, 2024

Business Wire 4 months ago

ALMDT.PA
-6.25%
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31st, 2024

SOPHIA ANTIPOLIS, France, September 06, 2024--Regulatory News: Median Technologies (Paris:ALMDT):

Business Wire 4 months ago

ALMDT.PA
-6.25%
Median Technologies to share positive pivotal data for eyonis™ LCS diagnostic software as medical device at the IASLC 2024 World Conference on Lung Cancer

SOPHIA ANTIPOLIS, France, September 04, 2024--Median to share positive pivotal data for eyonis™ LCS diagnostic software as medical device at the IASLC 2024 World Conference on Lung Cancer

Business Wire 4 months ago

ALMDT.PA
-6.25%
Median Technologies to host two webcasts on September 5, 2024

SOPHIA-ANTIPOLIS, France, September 02, 2024--Median Technologies to host two webcasts on September 5, 2024

Business Wire 4 months ago

ALMDT.PA
-6.25%
Median Technologies’ study of eyonis LCS meets endpoints

The eyonis LCS SaMD is designed to enhance the detection and diagnostic accuracy of LDCT for lung cancer screening.

Medical Device Network 4 months ago

ALMDT.PA
-6.25%
Median Technologies Announces Pivotal REALITY Study of Its eyonis™ LCS Lung Cancer Diagnostic Met All Primary and Secondary Endpoints

SOPHIA ANTIPOLIS, France, August 29, 2024--Median Technologies announces pivotal REALITY study of its eyonis™ LCS lung cancer diagnostic met all primary and secondary endpoints.

Business Wire 4 months ago

ALMDT.PA
-6.25%
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31st, 2024

SOPHIA ANTIPOLIS, France, August 08, 2024--Disclosure of total number of voting rights and number of shares in the capital as of July 31st, 2024

Business Wire 5 months ago

ALMDT.PA
-6.25%
Median Technologies Partners with a Top 10 Oncology Pharma Company to Apply AI for Imaging Biomarker Discovery

SOPHIA ANTIPOLIS, France, August 06, 2024--Median Technologies Partners with a Top 10 Oncology Pharma Company to Apply AI for Imaging Biomarker Discovery

Business Wire 5 months ago

ALMDT.PA
-6.25%
Median Technologies Reports Record iCRO Backlog, eyonis™ LCS On-Track for Standalone Pivotal Study Readout in August

SOPHIA ANTIPOLIS, France, July 18, 2024--Median Technologies Reports Record iCRO Backlog, eyonis™ LCS On-Track for Standalone Pivotal Study Readout in August

Business Wire 5 months ago

ALMDT.PA
-6.25%
Median Technologies: Financial Communication Schedule for the Second Half of 2024

SOPHIA ANTIPOLIS, France, July 11, 2024--Financial communication schedule for the second half of 2024

Business Wire 6 months ago

ALMDT.PA
-6.25%

Performance Overview

Return	ALMDT.PA	CAC 40
YTD	+27.66%	+5.42%
1-Year	+14.29%	+4.21%
3-Year	-69.31%	+7.93%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Median Technologies SA (ALMDT.PA)

Median Technologies: Financial Communications Schedule for the First Half of 2025

Half Year Median Technologies Liquidity Contract Statement

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31st, 2024

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2024

Median Technologies to Showcase AI-Powered Lung Cancer Diagnostic eyonis™ LCS at the Radiological Society of North America (RSNA) 2024

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2024

Median Technologies Hosted Insightful Key Opinion Leader (KOL) Webinar on eyonis™ Lung Cancer Screening (LCS) REALITY Data

Median Technologies to Host Key Opinion Leader (KOL) Webinar on AI and Lung Cancer Screening

Median Technologies Reports 2024 Q3 Operational and Financial Update and 2024 Half-Year Results

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30th, 2024

Median Technologies to Attend and Present at the ESMO Congress 2024, Being Held in Barcelona, Spain, from Sept 13-17, 2024

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31st, 2024

Median Technologies to share positive pivotal data for eyonis™ LCS diagnostic software as medical device at the IASLC 2024 World Conference on Lung Cancer

Median Technologies to host two webcasts on September 5, 2024

Median Technologies’ study of eyonis LCS meets endpoints

Median Technologies Announces Pivotal REALITY Study of Its eyonis™ LCS Lung Cancer Diagnostic Met All Primary and Secondary Endpoints

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31st, 2024

Median Technologies Partners with a Top 10 Oncology Pharma Company to Apply AI for Imaging Biomarker Discovery

Median Technologies Reports Record iCRO Backlog, eyonis™ LCS On-Track for Standalone Pivotal Study Readout in August

Median Technologies: Financial Communication Schedule for the Second Half of 2024

Performance Overview